/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

days · browse · Enter similar · o open

Tel Aviv-based Cymulate, which helps cybersecurity teams stress test their networks, raised a $70M Series D led by One Peak, sources say at a ~$500M valuation

Ingrid Lunden / TechCrunch :

TechCrunch Ingrid Lunden

Context & Ripple Effects

Cymulate's new round is a repeat bet: One Peak, which led the company's $45M Series C in May 2021, is leading again at a reported ~$500M valuation — steady step-up financing for a Tel Aviv team selling simulated attacks as a service. That puts Cymulate on a slower valuation curve than the last generation of AI-security names: Cylance crossed the billion-dollar mark back in 2016 on a bigger $100M Series D.

The raise lands in a crowded Israeli security cluster where specialization is the norm — Cylus just took $30M for rail-network defense and Cyolo raised $60M for zero-trust access two months before this deal — so Cymulate's differentiation is the testing side of the stack rather than another prevention product.

First-order effects

  • One Peak now has consecutive leads across Cymulate's last two rounds, deepening its exposure and giving the company an extended runway to push breach-and-attack simulation deeper into enterprise security budgets.
  • Security teams buying Cymulate get a signal the category is durably funded, reducing vendor-viability risk at renewal time.

Second-order effects

  • Prevention-led vendors like Cylance-style AI detection shops face budget competition from validation tools: every dollar a customer spends proving defenses work is a dollar scrutinized before it goes to more detection.
  • Adjacent Israeli specialists such as Cyolo and Cylus now benchmark against Cymulate's ~$500M mark when pricing their own next rounds, since investors can compare notes across the same ecosystem.

Third-order effects

  • If the pattern holds, Israeli cybersecurity consolidates into two tiers — mega-round outliers like Cyera's later $12B data-security raise and steady mid-stage operators like Cymulate — forcing mid-tier founders to pick between category leadership and early exit.
  • Continuous validation becoming a funded, repeat-backed category points toward security procurement shifting from buying point products to buying proof they work.

The trend: Enterprise security spending is shifting from accumulating defensive tools toward continuously validating them, with repeat specialist investors underwriting the shift through Israel's security startup cluster.